U.S. health officials want to loosen marijuana restrictions. Here's what it means

If marijuana is downgraded to a Schedule III drug, it could be a huge boost to a struggling industry.

from Health and Science https://ift.tt/zcGW8BY
https://ift.tt/wTJjS5D
https://ift.tt/OqxLouF

McConnell suffering 'occasional lightheadedness' but is clear to keep working after freezing up in press conference, his doctor says

"Occasional lightheadedness is not uncommon in concussion recovery and can also be expected as a result of dehydration," Dr. Brian Monahan said in a letter.

from Health and Science https://ift.tt/ApNLB8P
https://ift.tt/wTJjS5D
https://ift.tt/OqxLouF

Ozempic could be the next target of Medicare drug price negotiations – here's why

Wall Street analysts expect Ozempic to be selected for price negotiations in 2025 due to the amount of money Medicare Part D already spends on the drug.

from Health and Science https://ift.tt/93zXYZ0
https://ift.tt/wTJjS5D
https://ift.tt/OqxLouF

HHS calls for easing restrictions on marijuana, sending cannabis stocks higher

That move could potentially expand the market for cannabis, sending shares of Canopy Growth, Tilray Brands and Cronos Group higher.

from Health and Science https://ift.tt/qRva3hi
https://ift.tt/Tl9qwFO
https://ift.tt/qr5caSh

Medicare wants to cut the price on an Eli Lilly drug. What it means for LLY shares

Lilly's Jardiance is among the first 10 prescription drugs subject a new, contentious negotiation process between Medicare and drugmakers.

from Health and Science https://ift.tt/Q6I0nDi
https://ift.tt/Tl9qwFO
https://ift.tt/qr5caSh

Medicare drug price negotiations may have a muted impact on drugmakers in the near term

Many of the drugs are already facing strong competition from other branded medications or patent expirations that will open the market to generic alternatives. 

from Health and Science https://ift.tt/NzmgEhQ
https://ift.tt/Tl9qwFO
https://ift.tt/qr5caSh

Hurricane Idalia slams Florida coast with 'catastrophic' storm surge, damaging winds

Hurricane Idalia slammed Florida's Big Bend coast with maximum sustained winds of more than 100 miles per hour and catastrophic flooding.

from Health and Science https://ift.tt/HTC0hdM
https://ift.tt/Tl9qwFO
https://ift.tt/qr5caSh

Covid fraud: Street gang in Milwaukee allegedly stole millions to pay for murder, guns and drugs

A Milwaukee street gang called the "Wild 100s" allegedly stole millions of dollars in Covid unemployment benefits.

from Health and Science https://ift.tt/60AiDGu
https://ift.tt/KTwV06j
https://ift.tt/U6VEl2P

Medicare pricing deal set to play a key role in Biden's 2024 campaign pitch

President Joe Biden is placing a priority on reducing individual health-care costs as he seeks reelection.

from Health and Science https://ift.tt/2Q3YLuO
https://ift.tt/KTwV06j
https://ift.tt/U6VEl2P

Here are the three most used drugs on the Medicare price negotiation list

The Biden administration unveiled the much-awaited list officially kicking off a process that aims to control rising drug costs in the U.S.

from Health and Science https://ift.tt/6hVOgI3
https://ift.tt/KTwV06j
https://ift.tt/U6VEl2P

House Majority Leader Steve Scalise has a 'very treatable' blood cancer

House Majority Leader Steve Scalise said he has been diagnosed with multiple myeloma.

from Health and Science https://ift.tt/zaU1vW2
https://ift.tt/KTwV06j
https://ift.tt/U6VEl2P

Biden administration unveils first 10 drugs subject to Medicare price negotiations

The announcement of the 10 drugs kicks off a Medicare negotiation process that aims to make costly medications more affordable for older Americans. 

from Health and Science https://ift.tt/vy3qbRl
https://ift.tt/KTwV06j
https://ift.tt/U6VEl2P

The ADHD drug market is already stretched thin. Now it's facing a back-to-school supply strain

It's been 10 months since the FDA first announced a nationwide shortage of Adderall and the supply strain could worsen in the months ahead.

from Health and Science https://ift.tt/RHKMgES
https://ift.tt/erV1gUC
https://ift.tt/m2i9HJq

Here are the 8 trades and 3 price-target changes we made during a busy week

The Club's portfolio underwent considerable change in a week dominated by Nvidia's earnings and the run-up to the Fed's Jackson Hole symposium.

from Health and Science https://ift.tt/5LoUKWN
https://ift.tt/S75sFiL
https://ift.tt/Q7FbwCt

Wegovy helps reduce heart failure symptoms in obese people, study says

The trial results add to Wegovy's growing list of potential health benefits beyond shedding unwanted pounds.

from Health and Science https://ift.tt/3wGqLSj
https://ift.tt/S75sFiL
https://ift.tt/Q7FbwCt

3 things point to better times ahead for this maker of X-Ray and MRI machines

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

from Health and Science https://ift.tt/nwcKAmR
https://ift.tt/S75sFiL
https://ift.tt/Q7FbwCt

CDC expects new Covid vaccines from Pfizer, Moderna and Novavax to be available in mid-September

The updated Covid vaccines from Pfizer, Moderna and Novavax still need green lights from the FDA and the CDC before they roll out to the public.

from Health and Science https://ift.tt/p7eFiak
https://ift.tt/S75sFiL
https://ift.tt/Q7FbwCt

CVS pushes into making cheaper versions of complex drugs with new discount Humira

CVS is looking to strengthen its foothold in the biosimilars market, which is expected to grow to $100 billion over the next six years.

from Health and Science https://ift.tt/Bf8xJiM
https://ift.tt/D8zTMRC
https://ift.tt/cY1Ond4

Juul to cut 30% of its workforce in bid to cut costs and boost profitability

Juul is awaiting a decision from U.S. regulators on whether its products can remain on the market.

from Health and Science https://ift.tt/0zlaM9e
https://ift.tt/D8zTMRC
https://ift.tt/cY1Ond4

China is furious with Japan's plan to release treated Fukushima water into the ocean

The imminent water release comes more than a decade after Japan was rocked by the second-worst nuclear disaster in history.

from Health and Science https://ift.tt/TbFcES7
https://ift.tt/4ZKiPSJ
https://ift.tt/JUBNWIb

Novavax shares surge after drugmaker says new Covid vaccine was effective against Eris variant

Novavax's vaccine and new shots from Pfizer and Moderna are expected to roll out in the U.S. within weeks, pending potential approvals from the FDA.

from Health and Science https://ift.tt/DNbGLTt
https://ift.tt/4ZKiPSJ
https://ift.tt/JUBNWIb

FDA approves Pfizer maternal RSV vaccine for infants

Pfizer hopes that its respiratory syncytial virus vaccine will be available to the public by the end of October or the beginning of November.

from Health and Science https://ift.tt/72Dserf
https://ift.tt/Us2vFQc
https://ift.tt/sViRjSN

Teva to pay $225 million in fines and divest generic drug to resolve price-fixing charges

It's the latest resolution in a string of cases related to price-fixing, referring to competitors banding together to artificially set the price of a product. 

from Health and Science https://ift.tt/Vb3PhUp
https://ift.tt/Us2vFQc
https://ift.tt/sViRjSN

Covid vaccine stocks jump as new variants emerge ahead of fall shot rollout

Novavax, Moderna, Pfizer and its partner BioNTech are slated to roll out new shots designed to target the omicron subvariant XBB.1.5 this fall.

from Health and Science https://ift.tt/bdYG46W
https://ift.tt/Us2vFQc
https://ift.tt/sViRjSN

This biotech name is one of Jim Cramer's favorite stocks and he thinks it can go even higher

"I think it's going to be worth more," Jim Cramer said Monday after Regeneron got good news from the FDA on its macular degeneration treatment.

from Health and Science https://ift.tt/GFo1gCj
https://ift.tt/Us2vFQc
https://ift.tt/sViRjSN

We're buying more of 2 stocks, deploying some of our cash pile in an oversold market

We're putting a little more of our big cash position to work Monday into the oversold market.

from Health and Science https://ift.tt/1NxjEki
https://ift.tt/Us2vFQc
https://ift.tt/sViRjSN

New Covid vaccines from Pfizer, Moderna and Novavax will likely protect against Eris variant

The drugmakers designed their updated coronavirus shots to target the omicron subvariant XBB.1.5, which is slowly declining nationwide.

from Health and Science https://ift.tt/bB2NJoY
https://ift.tt/npv0qCr
https://ift.tt/9UY80zD

Moderna says new Covid vaccine was effective against Eris variant in early trial

Moderna's vaccine and new shots from Pfizer and Novavax are slated to roll out within weeks, pending potential approvals from the Food and Drug Administration. 

from Health and Science https://ift.tt/t9XJ36A
https://ift.tt/sex8ZYu
https://ift.tt/JTkXxBr

These are the top 5 performing Club stocks from mid-July to our August Monthly Meeting

Since the CNBC Investing Club's July Monthly Meeting, the stock market has seesawed up and then down.

from Health and Science https://ift.tt/vb8OexF
https://ift.tt/sex8ZYu
https://ift.tt/JTkXxBr

CVS stock plunges after Blue Shield of California drops retailer's pharmacy services to save on drug costs

Blue Shield's announcement hints at the potential for health insurers to abandon the traditional pharmacy benefit management system.

from Health and Science https://ift.tt/RVLHh47
https://ift.tt/sex8ZYu
https://ift.tt/JTkXxBr

Blue Shield of California taps Amazon, Mark Cuban's Cost Plus Drugs for its pharmacy network

The nonprofit health insurer, with 4.8 million members, expects the move to the low-cost pharmacies will provide $500 million in annual savings on drug costs.

from Health and Science https://ift.tt/pOET0Ku
https://ift.tt/sex8ZYu
https://ift.tt/JTkXxBr

Wegovy could prevent up to 1.5 million heart attacks, strokes over 10 years, study says

The results complement the data Novo Nordisk released last week, which found Wegovy slashed the risk of serious heart problems and heart-related death by 20%. 

from Health and Science https://ift.tt/p2xrdh3
https://ift.tt/gk72Zt3
https://ift.tt/cZf2onP

Appeals court imposes restrictions on abortion pill, but drug will stay on the market for now

The order by the U.S. 5th Circuit Court of Appeals is almost certain to be appealed to the Supreme Court.

from Health and Science https://ift.tt/uNEPkF6
https://ift.tt/gk72Zt3
https://ift.tt/cZf2onP

Activists ease up on Salesforce — plus, 10 other Club stocks traded by Wall Street pros

Salesforce (CRM), Nvidia (NVDA) and Alphabet (GOOGL) were among the basket of Club stocks traded by high-profile investors in the second quarter.

from Health and Science https://ift.tt/cSrHxsG
https://ift.tt/gk72Zt3
https://ift.tt/cZf2onP

Eli Lilly gets a new price target after a big rally. Should I buy more shares?

Questions about price targets come up often and are always worth looking into.

from Health and Science https://ift.tt/WPoew7B
https://ift.tt/gk72Zt3
https://ift.tt/cZf2onP

Young people are at risk of harsh respiratory problems after 30 days of e-cigarette use, study says

Researchers urged drug regulators to consider the study findings and work to minimize the negative impact of electronic cigarette use on young people.

from Health and Science https://ift.tt/nP6i5XK
https://ift.tt/gk72Zt3
https://ift.tt/cZf2onP

YouTube will remove cancer treatment misinformation

YouTube announced a new policy for combatting medical misinformation on the video sharing platform

from Health and Science https://ift.tt/KlGDMvy
https://ift.tt/LBRrOkw
https://ift.tt/ogs4Ut1

As the new Eris Covid variant spreads across the world, here’s what we know so far

EG.5 or "Eris," now the dominant variant in the United States, is currently thought to have the same risk level as existing variants.

from Health and Science https://ift.tt/cqLaKdo
https://ift.tt/LBRrOkw
https://ift.tt/ogs4Ut1

Jim Cramer talks about his 'favorite stock,' telling investors to buy some as we did last week

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

from Health and Science https://ift.tt/w0hnOFD
https://ift.tt/LBRrOkw
https://ift.tt/ogs4Ut1

SEC investigating Illumina over acquisition of cancer test developer Grail

Illumina's acquisition of cancer test developer Grail has also faced heavy scrutiny from antitrust regulators in the U.S. and European Union.

from Health and Science https://ift.tt/Wb6ZOUQ
https://ift.tt/fQoO81p
https://ift.tt/EpeALIP

Hawaii wildfires: Biden vows immediate aid, deploys military to assist victims

Biden declared a major disaster in Hawaii two days after wildfires rapidly swept across parts of Maui, devastating the historic city of Lahaina.

from Health and Science https://ift.tt/7oEuj3n
https://ift.tt/ifMVQG7
https://ift.tt/w74Ooc1

These 10 medications are likely targets for Medicare price negotiations this fall

It's still unclear which drugs Medicare will select, but several companies have revealed in court filings that four of their medications are targets.

from Health and Science https://ift.tt/dAVcMqW
https://ift.tt/ifMVQG7
https://ift.tt/w74Ooc1

Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion

Inversago's drugs use a different approach than most treatments in the obesity and diabetes space.

from Health and Science https://ift.tt/VGcCTRy
https://ift.tt/ifMVQG7
https://ift.tt/w74Ooc1

Wegovy-maker Novo Nordisk raises outlook as sales of its weight-loss drug soar

The Danish company's diabetes and obesity division performed particularly well, bolstered by interest in its blockbuster injection Wegovy.

from Health and Science https://ift.tt/NABqKHU
https://ift.tt/Z5A6zQH
https://ift.tt/yxZrido

Abortion rights keep winning on the ballot in conservative states — Florida and Arizona could be next

Ohio is the latest in a string of conservative states to reject GOP-backed campaigns to make constitutional changes targeting abortion rights.

from Health and Science https://ift.tt/fMcIFDk
https://ift.tt/Z5A6zQH
https://ift.tt/yxZrido

Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data

There is likely a long way to go before the U.S. sees increased insurance coverage of obesity drugs, but Novo Nordisk's new data is a meaningful start.

from Health and Science https://ift.tt/I9MV8bB
https://ift.tt/Z5A6zQH
https://ift.tt/yxZrido

We're optimistic about this struggling entertainment stock despite an expected weak quarter

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

from Health and Science https://ift.tt/PXaSkOx
https://ift.tt/Z5A6zQH
https://ift.tt/yxZrido

Obesity drug Wegovy's landmark trial result could 'open up' health insurance access, analyst says

Popular weight-loss drug Wegovy could be made available under more health insurance schemes after the results of a late-stage trial pointed to the drug's efficacy in reducing cardiovascular events, analysts said Wednesday.

from Health and Science https://ift.tt/hCsDPSk
https://ift.tt/c2yfDE6
https://ift.tt/lPoaIEq

Amazon to offer reproductive care to more than 1 million employees through partnership with Maven Clinic

Amazon will now offer fertility and family planning services to more than 1 million employees across 52 countries through a partnership with Maven Clinic.

from Health and Science https://ift.tt/eaWVL8R
https://ift.tt/c2yfDE6
https://ift.tt/lPoaIEq

Ohio voters flock to the polls with abortion rights at stake in GOP-backed rules change

A GOP-backed effort to make it more difficult to amend the constitution comes ahead of a fall referendum to enshrine abortion rights in Ohio.

from Health and Science https://ift.tt/LgYv7lk
https://ift.tt/c2yfDE6
https://ift.tt/lPoaIEq

Here's what is behind the stock market's selloff and what we're doing about it

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

from Health and Science https://ift.tt/lmCSUQ3
https://ift.tt/c2yfDE6
https://ift.tt/lPoaIEq

Eli Lilly raises full-year guidance as drug pipeline drives second-quarter profit up 85%

Eli Lilly's stock has been on a tear, driven by positive trial results for its Alzheimer's drug and progress with its promising obesity drug pipeline. 

from Health and Science https://ift.tt/lLOv8RA
https://ift.tt/gqL5frV
https://ift.tt/a6vzKXf

Red Cross ends blood donation restrictions that singled out gay and bisexual men

The FDA in May dropped a nearly 40-year policy that had singled out men who have sex with men.

from Health and Science https://ift.tt/iW0KTjI
https://ift.tt/gqL5frV
https://ift.tt/a6vzKXf

I had a doctor's visit powered by A.I. — here's what it was like

Microsoft's Nuance developed DAX Express, a generative A.I.-powered clinical documentation app that creates those critical doctor's notes – instantly.

from Health and Science https://ift.tt/qF74s9p
https://ift.tt/gqL5frV
https://ift.tt/a6vzKXf

How hospitals are using A.I. to fight doctor burnout

Hospitals are looking at ways to leverage artificial intelligence to cut down on administrative tasks which contribute to burnout for nurses and doctors.

from Health and Science https://ift.tt/MnNCdHr
https://ift.tt/gqL5frV
https://ift.tt/a6vzKXf

Here are the 5 price-target changes and 4 trades we made during this busy earnings week

Many of these moves stemmed from what we saw in quarterly numbers and heard on conference calls.

from Health and Science https://ift.tt/3kpF2gt
https://ift.tt/EWAmHC7
https://ift.tt/rqzkmiJ

Pfizer limits distribution of some drugs from North Carolina plant damaged by tornado

Pfizer's Rocky Mount facility supplies 8% of all sterile injectable medicines used in U.S. hospitals, including anesthesia, analgesia and anti-infectives.

from Health and Science https://ift.tt/5TZQdKm
https://ift.tt/EWAmHC7
https://ift.tt/rqzkmiJ

Troubled health name bounces after strong quarter and guidance. Here's our view on the stock

An initial nearly 9% rally in BHC to over $10 per share faded somewhat as investors tempered optimism over good results.

from Health and Science https://ift.tt/a2StMGR
https://ift.tt/PLJmHj9
https://ift.tt/tvUwLF5

Infant RSV shot faces final hurdle at CDC, could be available by fall

Sanofi has said the companies are prepared to roll the shot out before RSV season this fall and do not foresee any challenges meeting demand.

from Health and Science https://ift.tt/1fEWy56
https://ift.tt/xK4rnwz
https://ift.tt/xo1Xq6C

Moderna shares rise on better Covid vaccine outlook despite sharp drop in sales

Moderna and its rivals Pfizer and Novavax have all seen a steep drop in sales of Covid vaccines and treatments as the world moves on from the pandemic.  

from Health and Science https://ift.tt/K9qO4au
https://ift.tt/xK4rnwz
https://ift.tt/xo1Xq6C

Humana calms Wall Street's jitters with quarterly results, clearing way for stock to run higher

Humana's second-quarter numbers and forward commentary boost our confidence in the health insurer.

from Health and Science https://ift.tt/PLrmIhn
https://ift.tt/xK4rnwz
https://ift.tt/xo1Xq6C

Humana shares rise after insurer says medical costs came in lower than expected

The results ease investor concerns after Humana and rival UnitedHealth Group warned of a surge in demand for non-urgent surgeries and outpatient services.

from Health and Science https://ift.tt/VmRJujy
https://ift.tt/xK4rnwz
https://ift.tt/xo1Xq6C

GSK sues Pfizer in U.S. court for patent infringement over RSV vaccine

Both RSV vaccines were approved by the U.S. Food and Drug Administration for use in adults 60 and above.

from Health and Science https://ift.tt/bNkeXa5
https://ift.tt/xK4rnwz
https://ift.tt/xo1Xq6C

CVS beats on earnings and revenue as the company slashes costs

CVS is cutting costs as it pushes deeper into healthcare services after its acquisitions of Signify Health and Oak Street Health.

from Health and Science https://ift.tt/T1EMQv3
https://ift.tt/jsT6Xe4
https://ift.tt/APmvefn

Walgreens is now offering RSV vaccines for older adults

This is the first RSV season in which older adults have the option to get vaccinated against the virus.

from Health and Science https://ift.tt/WqyQxt0
https://ift.tt/jsT6Xe4
https://ift.tt/APmvefn

CVS to slash 5,000 jobs as company deepens costly health care push

The pharmacy chain had about 300,000 employees in the U.S. at the end of last year, according to a securities filing. 

from Health and Science https://ift.tt/dXJgj36
https://ift.tt/jsT6Xe4
https://ift.tt/APmvefn

Pfizer beats on earnings, but revenue misses as Covid product sales plummet

Pfizer is in a transition period as it pivots away from its blockbuster Covid vaccine and drug Paxlovid while the world emerges from the pandemic.

from Health and Science https://ift.tt/zvnerml
https://ift.tt/3gPL9Fl
https://ift.tt/xa2lnpG

Merck beats on revenue boosted by Keytruda sales, but posts quarterly loss due to Prometheus deal

Shares of Merck are down roughly 4% this year, with a market value of roughly $270 billion, making it the third largest pharmaceutical company based in the U.S.

from Health and Science https://ift.tt/QFkGL12
https://ift.tt/3gPL9Fl
https://ift.tt/xa2lnpG

Amazon rolls out its virtual health clinic nationwide

Amazon Clinic allows patients to connect with telemedicine providers to help receive treatment for common conditions such as acne and hair loss.

from Health and Science https://ift.tt/64iclwg
https://ift.tt/3gPL9Fl
https://ift.tt/xa2lnpG